Biotech

All Articles

Metsera join Amneal to lock down GLP-1 source

.With very early stage 1 records now out in the wild, metabolic illness clothing Metsera is throwing...

Rivus articles information to support muscle-sparing excessive weight drug claims

.Rivus Pharmaceuticals has actually introduced the information responsible for its period 2 weight p...

BMS pays $110M to develop T-cell therapy treaty, aiding Top get opportunity to improve prioritized pipeline

.Bristol Myers Squibb is actually paying for Main Medication $110 thousand ahead of time to establis...

Generate increases an additional $1B-plus Large Pharma relationship

.Novartis has tattooed a deal possibly worth more than $1 billion with Flagship-founded Generate: Bi...

Metsera GLP-1 records cut shows 7.5% effective weight loss at 36 days

.Lately debuted Metsera is actually unfolding some stage 1 record for its own GLP-1 receptor agonist...

Flagship wishes biotechs flock to Mirai to increase genetic medications

.Among the genetic medicines branches race, Flagship Pioneering is unveiling a brand-new business to...

BioAge eyes $180M coming from IPO, exclusive placement for obesity tests

.BioAge Labs is actually looking at about $180 million in initial proceeds from an IPO as well as a ...

Merck's LAG-3 combination falls short colon cancer cells period 3 research

.A try through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colorectal cancer...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand europeans ($ 200 million), cas...

BioAge produces $198M coming from IPO as obesity biotech participates in Nasdaq

.BioAge Labs is actually bringing in virtually $200 million via its Nasdaq IPO this morning, with th...